Genetic diversity in small cell lung carcinoma.
作者信息
Hayashi Takuo
机构信息
Department of Human Pathology, Juntendo University Graduate School of Medicine, Bunkyo-ku, Tokyo, Japan.
Diagnostic Pathology Center, Juntendo Hospital, Bunkyo-ku, Tokyo, Japan.
出版信息
Transl Lung Cancer Res. 2024 May 31;13(5):1169-1172. doi: 10.21037/tlcr-24-40. Epub 2024 May 17.
Abstract
摘要
相似文献
1
Genetic diversity in small cell lung carcinoma.
Transl Lung Cancer Res. 2024 May 31;13(5):1169-1172. doi: 10.21037/tlcr-24-40. Epub 2024 May 17.
2
Somatic mutations of STK11 gene in human papillomavirus positive and negative penile cancer.
Infect Agent Cancer. 2013 Jan 10;8(1):2. doi: 10.1186/1750-9378-8-2.
3
Comparative Analysis of Stk11/Lkb1 versus Pten Deficiency in Lung Adenocarcinoma Induced by CRISPR/Cas9.
Cancers (Basel). 2021 Feb 26;13(5):974. doi: 10.3390/cancers13050974.
4
Targeted sequencing of plasma cell-free DNA to predict response to PD1 inhibitors in advanced non-small cell lung cancer.
Lung Cancer. 2019 Nov;137:1-6. doi: 10.1016/j.lungcan.2019.09.005. Epub 2019 Sep 6.
5
Detection of human papillomavirus in non-small cell carcinoma of the lung.
Hum Pathol. 2015 Nov;46(11):1592-7. doi: 10.1016/j.humpath.2015.07.012. Epub 2015 Jul 29.
6
Integrative Analysis of a Large Real-World Cohort of Small Cell Lung Cancer Identifies Distinct Genetic Subtypes and Insights into Histologic Transformation.
Cancer Discov. 2023 Jul 7;13(7):1572-1591. doi: 10.1158/2159-8290.CD-22-0620.
7
[Expression and significance of P16INK4A and PTEN in high-risk human papillomavirus-related cervical cancer].
Ai Zheng. 2007 May;26(5):480-3.
8
Human Papillomavirus in Non-Small Cell Lung Carcinoma: Assessing Virus Presence in Tumor and Normal Tissues and Its Clinical Relevance.
Microorganisms. 2023 Jan 14;11(1):212. doi: 10.3390/microorganisms11010212.
9
Small molecules alter VEGFR and PTEN expression in HPV-positive and -negative SCC: new hope for targeted-therapy.
Anticancer Res. 2015 Mar;35(3):1389-99.
10
Human papillomavirus prevalence in lung carcinomas in Bulgaria.
Microbiol Immunol. 2017 Oct;61(10):427-432. doi: 10.1111/1348-0421.12535.
本文引用的文献
1
Tumor- and circulating-free DNA methylation identifies clinically relevant small cell lung cancer subtypes.
Cancer Cell. 2024 Feb 12;42(2):225-237.e5. doi: 10.1016/j.ccell.2024.01.001. Epub 2024 Jan 25.
2
Molecular and Pathologic Characterization of YAP1-Expressing Small Cell Lung Cancer Cell Lines Leads to Reclassification as SMARCA4-Deficient Malignancies.
Clin Cancer Res. 2024 May 1;30(9):1846-1858. doi: 10.1158/1078-0432.CCR-23-2360.
3
Thyroid transcription factor-1 (TTF-1) expression and the efficacy of combination therapy with immune checkpoint inhibitors and cytotoxic chemotherapy in non-squamous non-small cell lung cancer.
Transl Lung Cancer Res. 2023 Sep 28;12(9):1850-1861. doi: 10.21037/tlcr-23-331. Epub 2023 Sep 13.
4
Integrative Analysis of a Large Real-World Cohort of Small Cell Lung Cancer Identifies Distinct Genetic Subtypes and Insights into Histologic Transformation.
Cancer Discov. 2023 Jul 7;13(7):1572-1591. doi: 10.1158/2159-8290.CD-22-0620.
5
Comparison of ASCL1, NEUROD1, and POU2F3 expression in surgically resected specimens, paired tissue microarrays, and lymph node metastases in small cell lung carcinoma.
Histopathology. 2023 May;82(6):860-869. doi: 10.1111/his.14872. Epub 2023 Feb 14.
6
Expression patterns and prognostic relevance of subtype-specific transcription factors in surgically resected small-cell lung cancer: an international multicenter study.
J Pathol. 2022 Aug;257(5):674-686. doi: 10.1002/path.5922. Epub 2022 May 25.
7
Lung neuroendocrine neoplasms: recent progress and persistent challenges.
Mod Pathol. 2022 Jan;35(Suppl 1):36-50. doi: 10.1038/s41379-021-00943-2. Epub 2021 Oct 18.
8
Molecular Subtypes of Primary SCLC Tumors and Their Associations With Neuroendocrine and Therapeutic Markers.
J Thorac Oncol. 2022 Jan;17(1):141-153. doi: 10.1016/j.jtho.2021.08.763. Epub 2021 Sep 15.
9
Intrinsic Immunogenicity of Small Cell Lung Carcinoma Revealed by Its Cellular Plasticity.
Cancer Discov. 2021 Aug;11(8):1952-1969. doi: 10.1158/2159-8290.CD-20-0913. Epub 2021 Mar 11.
10
Patterns of transcription factor programs and immune pathway activation define four major subtypes of SCLC with distinct therapeutic vulnerabilities.
Cancer Cell. 2021 Mar 8;39(3):346-360.e7. doi: 10.1016/j.ccell.2020.12.014. Epub 2021 Jan 21.
Zotero 插件